Global law firm Ashurst Perkins Coie is advising H.B. Fuller Company ('H.B. Fuller') on the £715m recommended all-cash acquisition of Advanced Medical Solutions Group plc ('AMS') announced on 25 June.
H.B. Fuller is the world's largest pure-play adhesives provider, formulating, manufacturing and marketing adhesives, sealants and related specialty products to customers across a broad range of end markets, including aerospace and defence, packaging, hygiene, electronics, construction, transportation and healthcare.
Established in 1991, AMS is a leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for pa-tients and value for payers. The acquisition values the entire issued and to be issued ordinary share capital of AMS at approximately £659m and implies an enterprise value of approximately £715m.
The Ashurst Perkins Coie team is being led by partners Richard Ross (New York) and Karen Davies (London) and senior associate Colin Bugler (London). The team also includes corporate partners Christopher Wassman and Brandon Kaster, global loans partner Tim Rennie and competition partners Duncan Liddell and Christopher Williams. Partner Ruth Buchanan is advising on employment matters, partner Nicholas Gardner is advising on tax matters and partner LaDale George is advising on healthcare matters. Ashurst Perkins Coie teams in France (led by partner François Hellot), Germany (led by partner Jan Krekeler) and Indonesia (led by partner Ratih (Ipop) Nawangsari) are also advising.
This cross-border M&A mandate demonstrates the geographic reach, sector-depth and practice strength of Ashurst Perkins Coie.
